What do you believe is the single most important factor driving up the cost of living in Nigeria?

Dei Biopharma’s new pharmaceutical and vaccine plant in Wakiso will commence commercial production of non-beta lactam tablets and Hard Gelatin capsules in October.

This follows a recent approval from the National Drug Authority (NDA) for the plant to begin operations.

Dr Mathias Magoola, the founder and executive director of Dei Group Ltd, said everything has been set and they are only waiting for results from their research products submitted to the US-Food and Drug Administration (FDA) for review and approval.

In May, the NDA issued two licences to the firm where the first one authorised them to manufacture medicine, including Non-Beta Lactam tablets and Hard Gelatin capsules used in treating infections while the second certificate endorsed the suitability of the premises.

The plant’s generic section, which can produce 150 different types of drugs, will start with 25 types, including capsules and tablets.

• Read More